Literature DB >> 23062327

Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations.

Michael R Sargen1, Ole Hoffstad, David J Margolis.   

Abstract

AIMS: The purpose of this study was to identify the presence or absence of geographic variation in Medicare spending and mortality rates for diabetic patients with foot ulcers (DFU) and lower extremity amputations (LEA).
METHODS: Diabetic beneficiaries with foot ulcers (n=682,887) and lower extremity amputations (n=151,752) were enrolled in Medicare Parts A and B during the calendar year 2007. We used ordinary least squares (OLS) regression to explain geographic variation in per capita Medicare spending and one-year mortality rates.
RESULTS: Health care spending and mortality rates varied considerably across the nation for our two patient cohorts. However, higher spending was not associated with a statistically significant reduction in one-year patient mortality (P=.12 for DFU, P=.20 for LEA). Macrovascular complications for amputees were more common in parts of the country with higher mortality rates (P<.001), but this association was not observed for our foot ulcer cohort (P=.12). In contrast, macrovascular complications were associated with increased per capita spending for beneficiaries with foot ulcers (P=.01). Rates of hospital admission were also associated with higher per capita spending and increased mortality rates for individuals with foot ulcers (P<.001 for health spending and mortality) and lower extremity amputations (P<.001 for health spending, P=.01 for mortality).
CONCLUSIONS: Geographic variation in Medicare spending and mortality rates for diabetic patients with foot ulcers and amputations is associated with regional differences in the utilization of inpatient services and the prevalence of macrovascular complications.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23062327      PMCID: PMC3673572          DOI: 10.1016/j.jdiacomp.2012.09.003

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  25 in total

1.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

2.  Survival following lower-limb amputation in a veteran population.

Authors:  J A Mayfield; G E Reiber; C Maynard; J M Czerniecki; M T Caps; B J Sangeorzan
Journal:  J Rehabil Res Dev       Date:  2001 May-Jun

Review 3.  Global and societal implications of the diabetes epidemic.

Authors:  P Zimmet; K G Alberti; J Shaw
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

4.  Health and economic burden of the projected obesity trends in the USA and the UK.

Authors:  Y Claire Wang; Klim McPherson; Tim Marsh; Steven L Gortmaker; Martin Brown
Journal:  Lancet       Date:  2011-08-27       Impact factor: 79.321

5.  The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care.

Authors:  Elliott S Fisher; David E Wennberg; Thérèse A Stukel; Daniel J Gottlieb; F L Lucas; Etoile L Pinder
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

6.  Geographic variation in pharmacotherapy decisions for U.S. Medicare enrollees with diabetes.

Authors:  Michael R Sargen; Ole J Hoffstad; Douglas J Wiebe; David J Margolis
Journal:  J Diabetes Complications       Date:  2012-05-31       Impact factor: 2.852

7.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.

Authors:  N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh
Journal:  Lancet       Date:  2010-06-26       Impact factor: 202.731

8.  Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology.

Authors:  Probal K Moulik; Robert Mtonga; Geoffrey V Gill
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

9.  Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance.

Authors:  Hui-Young Lee; Cheol Soo Choi; Andreas L Birkenfeld; Tiago C Alves; Francois R Jornayvaz; Michael J Jurczak; Dongyan Zhang; Dong Kyun Woo; Gerald S Shadel; Warren Ladiges; Peter S Rabinovitch; Janine H Santos; Kitt F Petersen; Varman T Samuel; Gerald I Shulman
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

10.  Location, location, location: geographic clustering of lower-extremity amputation among Medicare beneficiaries with diabetes.

Authors:  David J Margolis; Ole Hoffstad; Jeffrey Nafash; Charles E Leonard; Cristin P Freeman; Sean Hennessy; Douglas J Wiebe
Journal:  Diabetes Care       Date:  2011-09-20       Impact factor: 19.112

View more
  27 in total

1.  Costs and clinical quality among Medicare beneficiaries: associations with health center penetration of low-income residents.

Authors:  Ravi Sharma; Lydie A Lebrun-Harris; Quyen Ngo-Metzger
Journal:  Medicare Medicaid Res Rev       Date:  2014-09-08

2.  Diabetic foot complications and their risk factors from a large retrospective cohort study.

Authors:  Khalid Al-Rubeaan; Mohammad Al Derwish; Samir Ouizi; Amira M Youssef; Shazia N Subhani; Heba M Ibrahim; Bader N Alamri
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

3.  Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers.

Authors:  Jeff Y Yang; Tiansheng Wang; Virginia Pate; Emily W Gower; Matthew J Crowley; John B Buse; Til Stürmer
Journal:  Diabetes Obes Metab       Date:  2019-03-04       Impact factor: 6.577

Review 4.  Biology and Biomarkers for Wound Healing.

Authors:  Linsey E Lindley; Olivera Stojadinovic; Irena Pastar; Marjana Tomic-Canic
Journal:  Plast Reconstr Surg       Date:  2016-09       Impact factor: 4.730

5.  Metataxonomic approach to decipher the polymicrobial burden in diabetic foot ulcer and its biofilm mode of infection.

Authors:  Karthika Suryaletha; Joby John; Megha Periyappilly Radhakrishnan; Sanil George; Sabu Thomas
Journal:  Int Wound J       Date:  2018-01-22       Impact factor: 3.315

6.  Describing Normative Foot Temperatures in Patients With Diabetes-Related Peripheral Neuropathy.

Authors:  Brian M Schmidt; Sara Allison; James S Wrobel
Journal:  J Diabetes Sci Technol       Date:  2019-07-17

Review 7.  Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy.

Authors:  Prodromos Parasoglou; Smita Rao; Jill M Slade
Journal:  Clin Ther       Date:  2017-05-30       Impact factor: 3.393

Review 8.  Cost of diabetic eye, renal and foot complications: a methodological review.

Authors:  Solène Schirr-Bonnans; Nadège Costa; Hélène Derumeaux-Burel; Jérémy Bos; Benoît Lepage; Valérie Garnault; Jacques Martini; Hélène Hanaire; Marie-Christine Turnin; Laurent Molinier
Journal:  Eur J Health Econ       Date:  2016-03-14

Review 9.  Regenerative Medicine: Charting a New Course in Wound Healing.

Authors:  Geoffrey C Gurtner; Mary Ann Chapman
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-07-01       Impact factor: 4.730

10.  Improving outcomes for diabetic patients undergoing revascularization for critical limb ischemia: does the quality of outpatient diabetic care matter?

Authors:  Benjamin S Brooke; Larry W Kraiss; David H Stone; Brian Nolan; Randall R De Martino; Gayle E Reiber; David C Goodman; Jack L Cronenwett; Philip P Goodney
Journal:  Ann Vasc Surg       Date:  2014-06-06       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.